Ishchenko M M, Dorogiĭ A N, Nechaĭ E E, Shkrobot S I
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(9):1313-20.
In 370 atherosclerotic patients with chronic cerebrovascular insufficiency (CCVI) the authors have investigated the cerebral (by rheoencephalography) and the systemic (by diluting Evans blue) haemodynamics before and after correcting it with papaverine, euphylline, complamin, cavinton, corglycon, strophanthin, and sulfocamphocaine. They have also specified the characteristics of the action of the drugs studied, as well as indications and contraindications for their use in chronic CCVI treatment. The given therapy optimizes the current methods of rehabilitation of patients with chronic cerebrovascular insufficiency, ensures clinical improvement in 89.5% of cases (by 18.5% more than in the control group) and reduces the period of hospitalization by an average of 3.6 days.
在370例患有慢性脑血管供血不足(CCVI)的动脉粥样硬化患者中,作者研究了在用罂粟碱、氨茶碱、复方氨林巴比妥、长春西汀、强心灵、毒毛旋花子苷、硫卡因进行治疗前后的脑血流动力学(通过脑电阻抗图)和全身血流动力学(通过伊文思蓝稀释法)。他们还明确了所研究药物的作用特点,以及它们在慢性CCVI治疗中的适应证和禁忌证。所给予的治疗优化了慢性脑血管供血不足患者当前的康复方法,确保89.5%的病例临床症状改善(比对照组多18.5%),并使平均住院时间缩短3.6天。